GITAM Institute of Medical Sciences and Research achieves NABH Full Accreditation
Achieving NABH accreditation under the latest 6th edition standards signifies excellence in patient safety, clinical quality, infrastructure and continuous improvement, she said.
GIMSR head (operations) Krishna Karthik Bhogavalli spoke about the hospital's recent upgrades such as increasing the number of beds to 750 in number, 16 modular major operation theatres among others.
GIMSR NABH coordinator Prabhavathi mentioned that NABH accreditation stands as a testament to the GIMSR's unwavering commitment to quality healthcare, advanced medical education and continuous institutional excellence.
GIMSR hospital superintendent V.V. Narasimham Rao informed that GIMSR is empanelled with major government health schemes like NTR Vaidyaseva, BSKY, EHS, and ESI, along with leading TPAs for cashless insurance coverage.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
17-07-2025
- Time of India
Raj to promote medical tourism at global healthcare summits
Jaipur: The state govt will participate in global healthcare summits to showcase Rajasthan's progress in medical value travel (MVT). The medical education department said that they will attend national and international fairs, adding that the successful implementation of Rajasthan's MVT under Heal in Rajasthan (HIR) policy will require a structured year-wise action plan, clear resource allocation, and close coordination among key departments and partners. Under the newly formulated HIR policy on MVT, the state govt will launch targeted campaigns focusing on specific geographic areas or medical specialties to attract patient flow in the state. The govt will facilitate the upgradation of hospitals to international accreditation standards (NABH/JCI). The MVT cell will ensure all empanelled hospitals under MVT have regular staff training. It will liaise with the nursing council and national medical commission for the integration of MVT-specific curriculum (language, soft skills, etc. ). Cultural sensitisation programs for healthcare workers and support staff to understand and respect the cultural norms and expectations of patients coming in from different regions shall be encouraged, said a medical education department official. The MVT cell will liaise with the department of AYUSH for mainstreaming wellness treatments. Efforts will be made to provide a platform for establishing linkages between tourism units and global insurers and agencies. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Providers are furious: Internet access without a subscription! Techno Mag Learn More Undo Under the regulatory and institutional framework, the state govt will promote transparency in the pricing of various procedures across different hospitals, with the state govt holding regular interactions with hospitals. For promoting standardisation and ethical practices, the MVT cell will develop standard operating procedures and guidelines for the MVT stakeholders. A separate and independent body will be established for the timely resolution of disputes. The govt will encourage hospitals to adopt and use cutting-edge technologies for treatment and diagnostic purposes. The official said that govt will undertake interventions for the development of MVT infrastructure by promoting the development of new multi-speciality hospitals in line with international standards by encouraging them to invest in Rajasthan, leveraging incentives offered by various existing state policies. Public health institutes will be encouraged to develop facilities to attract medical value travellers. It will promote the development of MVT hubs with all the necessary facilities established under one roof, which may include tertiary care hospitals, attendants' accommodation, testing centres, diagnostic labs, rehabilitation centres and wellness centres.
Time of India
15-07-2025
- Time of India
Is India's Healthcare 'Broken' — or Just Misunderstood?
Over the past few decades, I have worked across the healthcare value chain — across public and private organizations beyond India in the U.S., U.K. and South- Asia in board and advisory roles. I also served for several years on the National Accreditation Board for Hospitals & Healthcare (NABH) committee, accrediting thousands of hospitals. Across these experiences, one reality has struck me repeatedly: we have misunderstood the real problems of Indian healthcare. Far too often, debates around India's healthcare focus on shortages of healthcare professionals (HCPs) or inadequate infrastructure. These arguments are often backed by archaic WHO ratios — such as doctors and beds per 1,000 population — which, frankly, lack both context and credibility today. WHO itself would struggle to explain when, how, and for which socio-economic setting these thresholds were designed. Yet, global and local critics alike parrot these outdated metrics while overlooking deeper systemic issues. In fact, India may not be suffering from a scarcity of healthcare professionals at all. If anything, our system faces three very different and more urgent problems: 1. Inefficient System Orientation 2. Unequal Distribution of HCPs and HCOs 3. Misaligned Payer and Financing Models Let me illustrate with ground reality: in years of NABH assessments, it was rare to find any hospital with more than 80% occupancy. Across most of India, the average hospital occupancy hovers around 40%. In some cases, these numbers may even be inflated to impress or to secure accreditation or medical seats from NMC. Contrast this with what patients in developed economies face. In the UK's NHS system or Canadian healthcare, it can take weeks to see a GP and months for a specialist. In the Nordic countries, cancer surgery can mean long waits — sometimes weeks, sometimes months. In the U.S., with all its market-driven mechanisms, demand often outpaces capacity in certain specialties. But in India, if you need a GP consult, a cancer specialist opinion, or even a complex procedure — you can get it today. No long queues. No booking six months in advance. As long as you can pay, healthcare is available on demand — in metros, in Tier 2 cities, even increasingly in Tier 3 towns. This raises an uncomfortable question: If we have so many underutilized hospitals and no waiting lists, is India's problem really a shortage of doctors and nurses? Or is it something else? The Real Issues First, systemic inefficiency. India's healthcare remains fragmented and unevenly regulated. Care pathways are often unclear. Too many institutions work in isolation instead of as an integrated continuum of care. Data remains siloed, and digital adoption, though improving, is uneven. Second, geographic maldistribution. India's healthcare providers — doctors, nurses, hospitals — are overwhelmingly concentrated in metros and richer states. According to NITI Aayog data, 3/4th of healthcare infrastructure serves urban India, which has 1/3rd of the population and roughly 3/4th of the population in rural Indian is served by about 1/3rd of healthcare providers. Southern and western states attract specialists, while many parts of the North-East, BIMARU states, and tribal belts remain under-served. Third, flawed payment and financing models. The majority of Indian healthcare is still out-of-pocket. Health insurance penetration is uneven and often insufficient. Ayushman Bharat and other government schemes are improving access but face coverage gaps and delayed reimbursements, which deter private participation. Meanwhile, there is little innovation in payer models — such as risk-pooling or value-based care — that can drive outcomes and sustainability. Time to Move Beyond WHO Ratios It is high time we move beyond outdated WHO ratios. In the 1950s or 1960s, such ratios may have helped post-colonial nations plan public health. But today, with technology enabling telehealth, AI-assisted triage, remote diagnostics, and advanced clinical decision support, we must rethink how many beds, doctors or nurses are truly needed, and where. Moreover, India produces more MBBS graduates today than many Western countries on a per capita basis. According to NMC data, India produces over 100,000 MBBS doctors annually — up from 40,000 a decade ago, and this likely to go up in the next 3 years. Similarly, nursing and allied health training has expanded. The real question is how to incentivize these professionals to work where they are needed — not whether we have 'enough.' The Way Forward Rather than 'cursing' Indian healthcare, it is time to realign and reposition it for the future: 1. Shift focus from input metrics to outcomes — Measure the quality and equity of healthcare, not just how many beds or doctors exist. 2. Incentivize balanced distribution — Use smart policies, blended financing, and public-private partnerships to move HCPs and HCOs into underserved geographies. 3. Innovate payment models — Move towards outcome-linked payer mechanisms, capitation models, and insurance innovations that reward preventive care and efficiency. 4. Embrace technology aggressively — Virtual hospitals, AI-led triage, remote monitoring, and integrated digital health records can overcome both geographic barriers and resource gaps. India is a young nation, with median age 29, and poised to lead the global digital economy. Healthcare in India is not as bad as it its projected but must evolve fast to realign and reorient to the developments to match the developments in digital age — not by chasing irrelevant WHO ratios but by designing a 21st-century system that delivers outcomes, equity, and efficiency. The glass is half full — but only if we stop looking at it through a broken lens. The article is written by Dr. Rajendra Pratap Gupta is the founder of global movement 'Digital Health Sans Borders' and Health Parliament, a globally revered think tank, and the former advisor to the Health Minister, Government of India. (DISCLAIMER: The views expressed are solely of the author and does not necessarily subscribe to it. shall not be responsible for any damage caused to any person/organisation directly or indirectly)
The Wire
10-07-2025
- The Wire
Apollo AyurVAID Launches India's First 'Tested Safe' Ayurveda Products
Bengaluru, Karnataka, India (NewsVoir) • Continues to build a full-stack Ayurveda enterprise with focus on comprehensive precision Ayurveda care and integrative medicine for patients across various clinical conditions • Launches 50 SKUs across classical Ayurveda formulations, OTC products, and medical foods • Targets nationwide reach and Rs. 500 crores in Products revenue in the next 5 years Apollo AyurVAID, India's leading NABH-accredited, precision Ayurveda hospital network, announces its strategic foray into the Ayurveda product segment, marking a significant expansion beyond clinical care. The new portfolio spans classical formulations, OTC products, and medical foods, crafted to meet the growing demand for safe, clinically validated Ayurveda products in India's ~ Rs. 60,000 crore market growing at over 16% annually. In an industry first, Apollo AyurVAID's product range features clinically proven formulations that are certified safe by NABL-accredited laboratories with respect to presence of heavy metals, aflatoxins, microbial content, etc., as applicable for different product types. Apollo AyurVAID's products set the highest, proof-backed, safety benchmark in the Ayurveda product market with the consumer able to verify test results (QR code on packaging) for each and every product they consume. This reinforces Apollo AyurVAID's resolve to offer safer, standardised, and effective Ayurveda products that the market can implicitly trust. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals and Chairperson, Apollo AyurVAID said, 'Apollo AyurVAID's foray into tested-safe Ayurveda products marks a pivotal step in redefining standards of safety, transparency, and efficacy in traditional medicine. This expansion builds on a strong foundation of clinical excellence and reflects a deep commitment to evidence-based, precision Ayurveda. By integrating innovation with time-honoured wisdom, Apollo AyurVAID is well on its way to shaping the future of integrative medicine in India and beyond.' Commenting on this strategic initiative, Mr. Rajiv Vasudevan, Founder, MD, and CEO, Apollo AyurVAID said, 'With two decades of clinical excellence behind us, we are extending our understanding of precision Ayurveda and credibility into a high-potential consumer space. This new vertical not only complements our inpatient-outpatient care model but also opens scalable revenue opportunities and reinforces our vision of mainstreaming evidence-based Ayurveda services and products by making it accessible globally. We anticipate this portfolio will be a key growth driver, with a revenue aspiration of Rs. 500 crores in the next 5 years.' The Ayurveda products division is being developed as a business unit of Apollo AyurVAID, while staying firmly rooted in Apollo AyurVAID's commitment to precision Ayurveda for personalised, safe, clinical-outcomes-driven health care.. While classical formulations will be available through prescription, the OTC and medical foods lines will be available through a wide network of retail and digital platforms. The OTC range features innovative medicine formats such as creams, transdermal pads, essential extracts, etc., for special customer segments (women, child, elder, etc.) and applications (pain, sleep, stress, skin etc.), with highest medical content assuring best-in-class product performance. Apollo AyurVAID has recently partnered with integrated systems biology platform company, Avesthagen Limited, to co-develop and offer scientifically validated, botanical-actives based dietary supplements that are sugar-free, artificial colour & flavours free; this shall be followed with an Ayurveda based medical foods range for specific clinical indications. The classical and OTC product range are branded 'AyurVAID' while the dietary supplements are branded 'AvestaAyurVAID'. This strategic expansion reinforces Apollo AyurVAID's vision of building a credible, science-led ecosystem for precision Ayurveda and evolving into a full-spectrum Ayurveda company. 'As we enter the Ayurveda products space, our broader vision is to take the Apollo AyurVAID brand across the length and breadth of India. In the current fiscal we plan to expand our hospital network in an asset-light manner by adding 9 new points of presence, scaling our bed capacity to 350, aiming to treat over 50,000 patients. With a CAGR of 75% over the last 2–3 years, we are on track to surpass the annualised Rs. 100 crore revenue mark by mid next year - an unprecedented milestone in Ayurveda's services sector. This is just the beginning of our journey to take Apollo AyurVAID, India's most credible, precision Ayurveda care, to every corner of the country and across the globe,' added Mr. Rajiv Vasudevan. Distribution for the new portfolio will follow a multi-tier strategy, with availability across Apollo AyurVAID's hospitals and clinics, the company's website, Apollo Pharmacies, Apollo 24|7 and leading e-commerce platforms. This integrated channel approach is designed to enable access and reach to a wider audience. About Apollo AyurVAID Apollo AyurVAID ( is India's leading chain of protocol-driven Ayurveda hospitals and integrative care centres, delivering evidence-based, 'Precision Ayurveda' for chronic disease reversal, management, and sustained wellbeing. Since its inception in 2005, Apollo AyurVAID has been committed to transforming Ayurveda into a mainstream, protocols, documentation and clinical-outcomes driven system of medicine with hospitals and clinics spread across Bengaluru, Chennai, New Delhi, Kochi, Almora and Hyderabad. Founded in 2005 and part of the Apollo group since 2022, Apollo AyurVAID has emerged as a pivotal force in formalising Ayurveda-led integrative care, developing a unique care model that combines traditional Ayurvedic wisdom with modern clinical rigour. The chain of hospitals has demonstrated an impactful model of integrative care across specialties including neurology, oncology, nephrology, obstetrics and gynaecology, and metabolic disorders, with a focus on adjuvant therapy, palliative care, rehabilitation, and primary intervention. Apollo AyurVAID's unique 'Whole Person Care' approach considers the whole person to treat multimorbidity, not just at symptom level but at root-cause level, and supports health across the entire life cycle, from prevention and treatment to rehabilitation, survivorship and wellbeing. The first and only Ayurveda institution to receive the prestigious QCI DL Shah National Quality Award (2012), Apollo AyurVAID is also India's first NABH-accredited Ayurveda hospital (2010). It is also the first to gain NABH accreditation for Ayurveda para surgery (2013) and five hospitals in its countrywide network are NABH-accredited. In 2023, it became the first and only QAI-accredited Ayurveda and integrative medicine based Transition Care Centre in India. (Disclaimer: The above press release comes to you under an arrangement with Newsvoir and PTI takes no editorial responsibility for the same.). PTI This is an auto-published feed from PTI with no editorial input from The Wire.
